Targeting Toxic Oligomeric Protein Variants Generated after Traumatic Brain Injury to Decrease Risk of AD Targeting toxic oligomeric protein variants generated after Traumatic Brain Injury to decrease risk of AD
|Effective start/end date||9/1/21 → 8/31/24|
- DOD-ARMY: Army Medical Research Acquisition Activity (USAMRAA) : $1,295,595.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.